We could not find any results for:
Make sure your spelling is correct or try broadening your search.
OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, Chief...
OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, is pleased to invite investors to...
Concurrently, the Company accepted the resignations of Dr. Colin Goddard and Mr. Joacim Borg OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and...
OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, today announces that Paul Romness...
OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, today announces that Paul Romness...
Company to ring Closing Bell at NYSE on Thursday, October 3, 2024 Interviews scheduled with Fintech.TV and Schwab Network OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -21.4285714286 | 2.8 | 2.9443 | 2.2 | 20166 | 2.61004907 | CS |
4 | -0.94 | -29.9363057325 | 3.14 | 3.15 | 2.2 | 17322 | 2.75922433 | CS |
12 | -1.99 | -47.4940334129 | 4.19 | 4.47 | 2.2 | 45853 | 3.44730425 | CS |
26 | -1.8 | -45 | 4 | 4.9 | 2.2 | 141643 | 3.72580939 | CS |
52 | -1.8 | -45 | 4 | 4.9 | 2.2 | 141643 | 3.72580939 | CS |
156 | -1.8 | -45 | 4 | 4.9 | 2.2 | 141643 | 3.72580939 | CS |
260 | -1.8 | -45 | 4 | 4.9 | 2.2 | 141643 | 3.72580939 | CS |
Symbol | Price | Vol. |
---|---|---|
UAVSAgEagle Aerial Systems Inc | US$ 3.58 (122.36%) | 167.29M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 29.60 (-0.30%) | 68.99M |
MSTZT Rex 2X Inverse MSTR Daily Target ETF | US$ 1.965 (0.26%) | 68.64M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6.08 (2.01%) | 59.01M |
TZADirexion Daily Small Cap Bear 3X Share New | US$ 11.41 (4.11%) | 39.08M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions